Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
pramipexol "aurobindo" 0,18 mg tabletter
aurobindo pharma (malta) limited - pramipexoldihydrochloridmonohydrat - tabletter - 0,18 mg
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
pramipexol "aurobindo" 0,35 mg tabletter
aurobindo pharma (malta) limited - pramipexoldihydrochloridmonohydrat - tabletter - 0,35 mg
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
pramipexol "aurobindo" 0,7 mg tabletter
aurobindo pharma (malta) limited - pramipexoldihydrochloridmonohydrat - tabletter - 0,7 mg
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
ramipril "aurobindo" 5 mg tabletter
aurobindo pharma (malta) limited - ramipril - tabletter - 5 mg
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
rizatriptan "aurobindo" 10 mg tabletter
aurobindo pharma (malta) limited - rizatriptanbenzoat - tabletter - 10 mg
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
sumatriptan "aurobindo" 100 mg tabletter
aurobindo pharma (malta) limited - sumatriptansuccinat - tabletter - 100 mg
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
sumatriptan "aurobindo" 50 mg tabletter
aurobindo pharma (malta) limited - sumatriptansuccinat - tabletter - 50 mg
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
rasagiline "amneal" 1 mg tabletter
amneal pharma europe limited - rasagilintartrat - tabletter - 1 mg
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
urispadol 200 mg tabletter
recordati ireland limited - flavoxathydrochlorid - tabletter - 200 mg
Unió Europea -
danès -
EMA (European Medicines Agency)
emtricitabine/tenofovir disoproxil mylan
mylan pharmaceuticals limited - emtricitabine, tenofovir disoproxil maleate - hiv infektioner - antivirale midler til systemisk anvendelse - treatment of hiv-1 infection:emtricitabine/tenofovir disoproxil mylan is indicated in antiretroviral combination therapy for the treatment of hiv-1 infected adults (see section 5. emtricitabine/tenofovir disoproxil mylan is also indicated for the treatment of hiv-1 infected adolescents, with nrti resistance or toxicities precluding the use of first line agents, (see sections 4. 2, 4. 4 og 5. pre-exposure prophylaxis (prep):emtricitabine/tenofovir disoproxil mylan is indicated in combination with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually acquired hiv-1 infection in adults and adolescents at high risk (see sections 4. 2, 4. 4 og 5.